Publications

Reset

January 2017

Authors: Marx-Stoelting P, Ganzenberg K, Knebel C, Schmidt F, Rieke S, Hammer H, Schmidt F, Potz O, Schwarz M, Braeuning A

Hepatotoxic effects of cyproconazole and prochloraz in wild-type and hCAR/hPXR mice

DOI

January 2017

Authors: Pasquevich KA, Bieber K, Gunter M, Grauer M, Potz O, Schleicher U, Biedermann T, Beer-Hammer S, Buhring HJ, Rammensee HG, Zender L, Autenrieth IB, Lengerke C, Autenrieth SE

Innate immune system favors emergency monopoiesis at the expense of DC-differentiation to control systemic bacterial infection in mice

DOI

January 2017

Authors: Beck F, Geiger J, Gambaryan S, Solari FA, Dell'Aica M, Loroch S, Mattheij NJ, Mindukshev I, Potz O, Jurk K, Burkhart JM, Fufezan C, Heemskerk JW, Walter U, Zahedi RP, Sickmann A

Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition

DOI

January 2017

Authors: Templin MF, Poetz O, Schwenk JM, Stoll D, Joos TO

Miniaturized Multiplexed Protein Binding Assays

DOI

January 2017

Authors: Sun L, Xiong X, Qiaogen Z, Pingkai O, Krastev R

Controlled heparinase-catalyzed degradation of polyelectrolyte multilayer capsules with heparin as responsive layer

DOI

December 2016

Authors: Sinnberg T, Makino E, Krueger MA, Velic A, Macek B, Rothbauer U, Groll N, Potz O, Czemmel S, Niessner H, Meier F, Ikenberg K, Garbe C, Schittek B

A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib

DOI

December 2016

Authors: Schelle J, Hasler L, Gopfert JC, Joos TO, Vanderstichele H, Stoops E, Mandelkow EM, Neumann U, Shimshek DR, Staufenbiel M, Jucker M, Kaeser SA

Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition

December 2016

Authors: Aroner SA, Rosner BA, Tamimi RM, Tworoger SS, Baur N, Joos TO, Hankinson SE

Plasma matrix metalloproteinase 2 levels and breast cancer risk

DOI

December 2016

Authors: Cheng F, Twardowski L, Fehr S, Aner C, Schaeffeler E, Joos T, Knorpp T, Dorweiler B, Laufer S, Schwab M, Torzewski M

Selective p38alpha MAP kinase/MAPK14 inhibition in enzymatically-modified LDL-stimulated human monocytes: implications for atherosclerosis

DOI

NMI Natural and Medical Sciences Institute
at the University of Tübingen
Markwiesenstraße 55, 72770 Reutlingen
Tel.: +49 7121 51530-0
Mail: info@nmi.de

Subsidiary company

Member of